Sign in to continue:

Wednesday, February 4th, 2026

Category: IPO

All News on IPO

OmniVision Integrated Circuits Group, Inc. Global Offering 2026: Hong Kong IPO Details, Application Process & Key Dates 2 3 7

OmniVision Integrated Circuits Group, Inc. Hong Kong IPO Analysis and Investment Outlook Company Name: OmniVision Integrated Circuits Group, Inc. Date of Prospectus: December 31, 2025 OmniVision Integrated Circuits Group, Inc. Launches Landmark Hong Kong...

GigaDevice Semiconductor Inc. Global Offering: Key Dates, Application Guide & Hong Kong IPO Details 2026

GigaDevice Semiconductor Inc. Hong Kong IPO: Key Analysis and Investor Guide GigaDevice Semiconductor Inc. Date of Prospectus: December 31, 2025 GigaDevice Semiconductor Inc. Launches Landmark Hong Kong IPO: Critical Insights for Investors GigaDevice Semiconductor...

Sichuan Biokin Pharmaceutical Hong Kong IPO: Innovative Oncology Drugs, Global Expansion & Key Financials (2025)

Baili Pharmaceutical IPO Analysis: Key Details, Financials, Risks, and Outlook Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical Hong Kong IPO: Strategic Growth in Oncology, Financials, and Investor Outlook IPO...

Sichuan Biokin Pharmaceutical Global Offering 2025: Hong Kong IPO Details, Application Process & Key Dates

Sichuan Biokin Pharmaceutical Co., Ltd. IPO Analysis Company Name: Sichuan Biokin Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Sichuan Biokin Pharmaceutical IPO: In-Depth Analysis, Offer Details, and Investor Insights Sichuan Biokin Pharmaceutical...

Japanese Pachinko & Real Estate Company IPO: Business Model, Market Strategies, and Investment Highlights for 2025

Libera IPO Analysis June 2025: Investment Opportunity, Financials, and Growth Outlook Libera Date of prospectus: June 2025 Libera IPO: High-Growth Japanese Tech Play Targets Nasdaq – Key Risks, Upside, and Investment Facts Libera, a...

Jinxun Group Hong Kong IPO: Global Copper & Cobalt Leader, ESG, Financials & Growth Strategy Explained

Yunnan Jinxun Resources Co., Ltd. IPO Analysis: Investor-Grade Deep Dive Yunnan Jinxun Resources Co., Ltd. Date of Prospectus: December 31, 2025 Yunnan Jinxun Resources: HKEX IPO Analysis, Cornerstone Investors, Offer Structure, and First-Day Listing...

Suzhou Ribo Life Science IPO: Leading the Future of siRNA Oligonucleotide Therapeutics – Company Overview, Pipeline, and Competitive Edge 1116272278

Suzhou Ribo Life Science Co., Ltd. IPO: Investor Analysis & Outlook Suzhou Ribo Life Science Co., Ltd. Date of prospectus: December 31, 2025 Suzhou Ribo Life Science IPO: In-Depth Analysis, Investor Insights & Listing...

MiniMax AI: Global Leader in Scalable Multi-Modal Foundation Models, Video Generation, and AI-Native Products

MiniMax Limited IPO Analysis: Comprehensive Investor Guide MiniMax Limited Date of Prospectus: December 31, 2025 MiniMax Limited IPO: A Deep Dive into the Largest AI Foundation Model Listing in Hong Kong MiniMax Limited, a...

Suzhou Ribo Life Science Co., Ltd. Global Offering: Hong Kong IPO Details, Application Process & Key Dates for 2026 2

Suzhou Ribo Life Science Co., Ltd. IPO Analysis: Comprehensive Investor Insights Company: Suzhou Ribo Life Science Co., Ltd. Date of Prospectus: December 31, 2025 Suzhou Ribo Life Science Co., Ltd. IPO: Detailed Analysis of...

Yunnan Jinxun Resources Co., Ltd. Global Offering: Key Dates, Application Process & IPO Details (Stock Code: 3636) 2

Yunnan Jinxun Resources Co., Ltd. IPO Analysis – 2025/2026 Hong Kong Listing Deep Dive Yunnan Jinxun Resources Co., Ltd. Date of prospectus: December 31, 2025 Yunnan Jinxun Resources Co., Ltd. Launches Hong Kong IPO:...